Syneron Medical (ELOS) Posts Q3 Loss of 20c, Misses Views by 5c
Syneron Medical Ltd. (NASDAQ: ELOS) reports Q3 EPS of ($0.20), versus the analyst estimate of ($0.15). Revenue for the quarter was $14.30 million, which compares to the estimate of $14.74 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
